Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups
✍ Scribed by Wenfeng Tan; Katsue Sunahori; Jian Zhao; Yun Deng; Kenneth M. Kaufman; Jennifer A. Kelly; Carl D. Langefeld; Adrienne H. Williams; Mary E. Comeau; Julie T. Ziegler; Miranda C. Marion; Sang-Cheol Bae; Joo Hyun Lee; Ji-Seon Lee; Deh-Ming Chang; Yeong Wook Song; Chack-Yung Yu; Robert P. Kimberly; Jeffrey C. Edberg; Elizabeth E. Brown; Michelle A. Petri; Rosalind Ramsey-Goldman; Luis M. Vilá; John D. Reveille; Marta E. Alarcón-Riquelme; BIOLUPUS; GENLES Networks; John B. Harley; Susan A. Boackle; Anne M. Stevens; R. Hal Scofield; Joan T. Merrill; Barry I. Freedman; Juan-Manuel Anaya; Lindsey A. Criswell; Chaim O. Jacob; Timothy J. Vyse; Timothy B. Niewold; Patrick M. Gaffney; Kathy L. Moser; Gary S. Gilkeson; Diane L. Kamen; Judith A. James; Jennifer M. Grossman; Bevra H. Hahn; George C. Tsokos; Betty P. Tsao
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 192 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To examine whether hydroxychloroquine (HCQ) usage is associated with a reduced risk of damage accrual in patients with systemic lupus erythematosus (SLE). ## Methods Patients (n = 518) meeting the American College of Rheumatology criteria for diagnosis of SLE and with ≤5
## Abstract ## Objective The A allele of the PD1.3 single‐nucleotide polymorphism (SNP) on the programmed cell death gene PDCD1 was markedly more frequent in patients with systemic lupus erythematosus (SLE) than in unaffected controls in a recent study involving large sets of Swedish, European Ame